Johnson & Johnson News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

21.01.14	J&J Q4 Profit Rises On Lower Charges, Results Top View; Guides 2014 In Line (RTTNews)
21.01.14	Johnson & Johnson Q4 Results Top View - Quick Facts (RTTNews)
21.01.14	Earnings Watch For January 21(JNJ, TRV, VZ, AMD, IBM, TXN) (RTTNews)
17.01.14	Bayer Says FDA Panel Votes Against Wider Use Of Blood Thinner Xarelto (RTTNews)
16.01.14	Carlyle Offers To Buy Johnson & Johnson Ortho-Clinical Diagnostics For $4.15 Bln (RTTNews)
16.01.14	Carlyle Group To Buy J&J's Ortho-Clinical Diagnostics Business For $4.15 Bln (RTTNews)
24.12.13	Reports: Carlyle Group In Exclusive Talks To Buy J&J's Clinical Diagnostics Unit (RTTNews)
05.12.13	Johnson & Johnson Firm To Pay $1.25 Mln To Settle Civil Money Penalty Action (RTTNews)
23.11.13	J&J, Medivir Get FDA Approval For Olysio To Treat Hepatitis C Virus Infection (RTTNews)
20.11.13	Vertex Sells Incivo Product Royalty Rights To Janssen Pharmaceutica For $152 Mln (RTTNews)
20.11.13	J&J's DuPuy Unit Reaches $2.5 Bln Deal To Compensate Revision Surgery Patients (RTTNews)
13.11.13	Reports: J&J Reach Over $4 Bln Deal To Settle Hip-implant Lawsuits (RTTNews)
05.11.13	J&J To Pay $2.2 Bln To Resolve Allegations Of Off-label Marketing, Kickbacks (RTTNews)
25.10.13	BABY Makes Big Leap, RIGL's Trial Flops, CLSN Warming Up To HEAT, NPSP On Watch (RTTNews)
18.10.13	Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx (PR Newswire)
17.10.13	Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2013 (PR Newswire)
17.10.13	Only One in Five People Consistently Recycles Packaging from Products Used in the Bathroom (PR Newswire)
15.10.13	Johnson & Johnson Lifts Full Year Earnings Forecast After Q3 Results Top View (RTTNews)
15.10.13	Pre-market Movers For Oct 15 (C, JNJ, KO, NFLX, SVNT, FLIR, DPZ) (RTTNews)
15.10.13	J&J Q3 Profit Edges Up; Adj. Earnings Beat Estimates; Lifts FY13 Adj. EPS View (RTTNews)
15.10.13	Earnings Watch For October 15 (C, KO, JNJ, INTC, YHOO) (RTTNews)
09.10.13	Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company (PR Newswire)
04.10.13	Morning Research: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc. (PR Newswire)
01.10.13	License Agreements, Strategic Partnerships, Regulatory Approvals, Acquisitions and Sale of Senior Notes - Research Report on Johnson & Johnson, Amgen, Gilead, MAKO, and Edwards Lifesciences (PR Newswire)
30.09.13	Drug Approvals, Trial Results, and Collaboration- Research Report on Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, AbbVie, and GSK (PR Newswire)
26.09.13	Regulatory Approvals, Positive Stock Price Movements, Optimistic Clinical Data, and New Launches and Contracts - Research Report on Johnson & Johnson, Celldex, Isis, Actavis, and Centene (PR Newswire)
25.09.13	Drug Recommendations, Presentations, Marketing Authorizations, and Board Appointments - Research Report on Johnson & Johnson, Lilly, Sanofi, GSK, and Pacira (PR Newswire)
24.09.13	Stock Movements, Quarterly Dividends and Product Recall News - Research Report on Pfizer, Johnson & Johnson, Bristol-Myers, Merck, and Abbvie (PR Newswire)
23.09.13	Conference Calls, New Appointments, Upcoming Presentations, Prospectus Filings and Acquisition Deal Updates - Research Report on Johnson & Johnson, WellPoint, Regeneron, Onyx, and MannKind (PR Newswire)
20.09.13	Conference Call, Presentation of Drug Trial Results, Breakthrough Therapy Designation, Positive Results, and Drug Revival - Research Report on Johnson & Johnson, Lilly, GSK, Kythera, and Sanofi (PR Newswire)
19.09.13	Legal Actions, Quarterly Dividends, Collaborations, and New Appointments - Research Report on Johnson & Johnson, Zoetis, Abbott, Teva Pharmaceuticals, and Baxter (PR Newswire)
18.09.13	Pipeline Developments, Product Recalls, Clinical Trial Results, Recognitions, and New Appointments - Research Report on Johnson & Johnson, Amgen, Regeneron, UnitedHealth, and Bristol-Myers (PR Newswire)
17.09.13	Johnson & Johnson to Host Conference Call on Third-Quarter Results (PR Newswire)
17.09.13	VisionCare Ophthalmic Technologies Secures Up To $15MM To Accelerate Growth Of Its Novel Treatment For Age-Related Macular Degeneration (PR Newswire)
10.09.13	FDA and EMA Submissions, Partnerships, Milestones, Participation Withdrawals, and Prequalifications - Research Report on Johnson & Johnson, Novartis, AstraZeneca, Astex Pharmaceuticals, and Sanofi (PR Newswire)
08.09.13	Reports: J&J Starts Sale Process For Clinical Diagnostics Unit (RTTNews)
04.09.13	Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference (PR Newswire)
03.09.13	Vivus Names Seth Fischer CEO, As Anthony Zook Resigns Due To Ill Health (RTTNews)
03.09.13	Kessler Topaz Meltzer & Check, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Johnson & Johnson Common Stock -- JNJ (PR Newswire)
02.09.13	Acquisitions, Topline Results, New Board Members, Events, and Product Milestones - Research Report on Johnson & Johnson, Sanofi, Lilly, AbbVie, and Novartis (PR Newswire)
29.08.13	Pre-Market Review: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc. (PR Newswire)
29.08.13	Acquisitions, Dividends, and Positive Data - Research Report on Onyx, Johnson & Johnson, Medtronic, Lilly, and Incyte (PR Newswire)
19.08.13	Johnson & Johnson Completes Acquisition Of Aragon Pharma (RTTNews)
19.08.13	Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc. (PR Newswire)
19.08.13	Drug Approvals, Clinical Trials, Awards, Offerings, and Earnings - Research Report on J&J, Sanofi, Novartis, BioScrip, and Pacira (PR Newswire)
14.08.13	Licenses, Phase III Trial Initiation and Results, and Investments - Research Report on Johnson & Johnson, Sanofi, AstraZeneca, Novartis, and GSK (PR Newswire)
06.08.13	Positive Opinions, Solid Margins, Agreements, and Clinical Trials to Boost Run Rate of Drug Manufacturers - Research Report on Johnson & Johnson, Pfizer, Merck, Bristol-Myers Squibb, and Lilly (PR Newswire)
31.07.13	Energizer Holdings To Buy Feminine Hygiene Business In U.S.,Canada And Caribbean (RTTNews)
30.07.13	Regulatory Approvals, Product Launches, and Steady Sales Show Signs of Growth - Research Report on Johnson & Johnson, Bristol-Myers Squibb, Actavis, Edwards Lifesciences, and Health Net (PR Newswire)
24.07.13	Morning Research: Johnson & Johnson, Mylan, Array BioPharma, and Brookdale Senior Living (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

mehr

08:39		Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen
27.12.24		Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus
27.12.24		BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
27.12.24		Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag
27.12.24		Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste
27.12.24		Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge